The effect of exercise intensity on skeletal muscle AMP-activated protein kinase (AMPK) signaling and substrate metabolism was examined in eight men cycling for 20 min at each of three sequential intensities: low (40 ؎ 2% VO 2 peak), medium (59 ؎ 1% VO 2 peak), and high (79 ؎ 1% VO 2 peak). Muscle free AMP/ATP ratio only increased at the two higher exercise intensities (P < 0.05). AMPK ␣1 (1.5-fold) and AMPK ␣2 (5-fold) activities increased from low to medium intensity, with AMPK ␣2 activity increasing further from medium to high intensity. The upstream AMPK kinase activity was substantial at rest and only increased 50% with exercise, indicating that, initially, signaling through AMPK did not require AMPK kinase posttranslational modification. Acetyl-CoA carboxylase (ACC)-␤ phosphorylation was sensitive to exercise, increasing threefold from rest to low intensity, whereas neuronal NO synthase (nNOS) phosphorylation was only observed at the higher exercise intensities. Glucose disappearance (tracer) did not increase from rest to low intensity, but increased sequentially from low to medium to high intensity. Calculated fat oxidation increased from rest to low intensity in parallel with ACC␤ phosphorylation, then declined during high intensity. These results indicate that ACC␤ phosphorylation is especially sensitive to exercise and tightly coupled to AMPK signaling and that AMPK activation does not depend on AMPK kinase activation during exercise.
A MP-activated protein kinase (AMPK) appears to be an important regulator of energy metabolism during skeletal muscle exercise (1, 2) . The AMPK isoforms ␣1 and ␣2 are expressed in skeletal muscle and are activated allosterically by increases in free AMP and by phosphorylation by an upstream kinase, AMPK kinase (1, 3) . Skeletal muscle AMPK kinase phosphorylation of the AMPK at Thr-172 is low at rest and increases during contraction (4 -6) , but the level of skeletal muscle AMPK kinase activity at rest and during exercise is not known.
Much of the support for AMPK's role in metabolic control has come from studies using the nucleoside intermediate 5-aminoimidazole-4-carboxyamide-ribonucleoside (AICAR), which is phosphorylated to form ZMP (AICA-ribotide) and activates AMPK (7) . When AICAR is administered to rats in vivo or in vitro in pharmacological doses, it activates AMPK in skeletal muscle and increases glucose uptake and fat oxidation (8 -10) . However, during exercise, skeletal muscle glucose uptake and fat oxidation do not always change in parallel. For example, during exercise at the same absolute workload, prior exercise training reduces glucose uptake but increases fat oxidation (11) . In addition, skeletal muscle glucose uptake increases with increasing exercise intensity (12, 13) , whereas fat oxidation increases with increasing exercise intensity up to ϳ65-70% VO 2 peak, but then decreases at higher exercise intensities (12, 13) . A number of human studies now suggest that the regulation of skeletal muscle AMPK ␣1 and ␣2 differs depending on the exercise intensity. AMPK ␣2 is activated during exercise at or above ϳ60% VO 2 peak (14 -16), whereas AMPK ␣1 is only activated during intense sprint type exercise in humans (14 -17) or during intense electrical stimulation in vitro in rat muscle (18) .
Skeletal muscle fat oxidation depends on fatty acids being transported into the mitochondria via carnitine palmitoyltransferase 1 (CPT1), which is inhibited allosterically by malonyl-CoA (19) . AMPK phosphorylates and inhibits acetyl-CoA carboxylase (ACC)-␤ (5, 20) , the enzyme responsible for malonyl-CoA production. Treadmill exercise increases skeletal muscle AMPK activity and ACC␤ phosphorylation and reduces ACC␤ activity and malonyl-CoA content in rats (5, 21) . In addition, activation of AMPK, by AICAR treatment, decreases ACC␤ activity and malonyl-CoA levels as well as increases fat oxidation in the perfused rat hindlimb (9) . ACC␤ activity decreases during exercise in humans at and above 60% VO 2 peak (22) , and decreases in malonyl-CoA are detected at intensities between 85 and 100% VO 2 peak but not at 60% VO 2 peak (22, 23) . We found that ACC␤ phosphorylation by AMPK at Ser-221 (MRPSMS 221 GLHLVKR) was increased greatly during prolonged exercise at ϳ60% VO 2 peak in human skeletal muscle (16) , consistent with the reduction in ACC␤ activity observed at this intensity (22) . Increased AMPK activity is not detected until ϳ60% VO 2 peak (14 -16), making it uncertain whether AMPK is responsible for ACC␤ phosphorylation and the increased fat oxidation accompanying low-intensity exercise (e.g., 40% VO 2 peak) (13) . At high exercise intensities (80 -100% VO 2 peak) (12,13), fat oxidation decreases despite both ACC␤ activity (22) and malonyl-CoA levels decreasing (22, 23) , which otherwise would be expected to drive fat oxidation. The drugs metformin and rosiglitazone, which are widely used to treat type 2 diabetes, have recently been found to activate AMPK in skeletal muscle of rats (24, 25) , and metformin activates AMPK in people with type 2 diabetes (26) . Because diet and exercise can reduce the risk of developing type 2 diabetes, considerable attention has been focused on the possible role of AMPK in these events. For these reasons, it was of interest to systematically examine the effect of low-, moderate-, and high-intensity exercise on AMPK signaling, including AMPK kinase activity and AMPK activity, ACC␤ phosphorylation, and fat oxidation.
There is conflicting evidence on the role of nitric oxide (NO) in regulating glucose uptake into skeletal muscle during exercise (27) (28) (29) (30) (31) (32) . Nevertheless, AMPK is associated with neuronal NO synthase (nNOS) and phosphorylates it during exercise in human skeletal muscle (16, 17) . Furthermore, AMPK is reported to activate skeletal muscle glucose uptake via a NO synthase-dependent pathway (33) . In this study, we examined nNOS phosphorylation in parallel with glucose uptake at varying exercise intensities.
RESEARCH DESIGN AND METHODS
Subjects. Eight healthy nonsmoking men provided informed written consent to participate in this study, which was approved by the Monash University Standing Committee for Research on Humans. The subjects' age, weight, and height were 28 Ϯ 2 years, 63.9 Ϯ 3.3 kg, and 179 Ϯ 3 cm, respectively (means Ϯ SE). Experimental procedures Preliminary testing. Peak pulmonary oxygen consumption during cycling (VO 2 peak) was determined using a graded exercise test to volitional exhaustion on a ergometer (Lode, Gronignen, the Netherlands) and averaged 3.08 Ϯ 0.35 l/min (47.9 Ϯ 4.5 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 ). On a separate day, subjects completed a familiarization trial in which they cycled for 1 h, spending 20 min at each of three sequential workloads, calculated from the VO 2 peak test, to be equivalent to 40% (low intensity), 60% (medium intensity), and 80% (high intensity) of their VO 2 peak, respectively. At least 5 days later, the subjects undertook their experimental trial. Experimental trial. Subjects (overnight fasted) reported to the laboratory in the morning having abstained from exercise, alcohol, and caffeine for 24 h. One catheter was inserted into an antecubital forearm vein for infusion of a glucose stable isotope tracer ( [6,6- 2 H]glucose; Cambridge Isotope Laboratories, Cambridge, MA) and another into the contralateral forearm for blood sampling. A blood sample was obtained; then a bolus of 41.2 Ϯ 0.5 mol/kg of the tracer was administered before a 2-h pre-exercise constant infusion (0.58 Ϯ 0.04 mol ⅐ kg Ϫ1 ⅐ min Ϫ1 ), which was continued throughout exercise. The exercise protocol consisted of cycling for 1 h, spending 20 min at each of three sequential workloads: low intensity: 40 Ϯ 2% VO 2 peak (75 Ϯ 12 W); medium intensity: 59 Ϯ 1% VO 2 peak (132 Ϯ 19 W); high intensity: 79 Ϯ 1% VO 2 peak (182 Ϯ 25 W). All subjects completed the protocol. Expired air was sampled into Douglas bags for ϳ15 min at rest, and then the last 3 min of each 20-min workload. Heart rate was monitored throughout exercise using a heart rate monitor (Polar Favor, Oulu, Finland). Muscle was sampled from the vastus lateralis muscle under local anesthetic using the percutaneous needle biopsy technique, with suction, at rest, and immediately at the completion of each 20-min period of exercise at four separate sites (resting and low-intensity samples were obtained from one leg, and medium-and high-intensity samples were obtained from the other leg). The resting muscle sample was frozen in liquid nitrogen within 4 Ϯ 0 s of inserting the needle, with the exercise samples frozen within 13 Ϯ 2 s of the subject stopping exercise. A standard 60-s period was allowed for completion of the biopsy and taping of the area before resuming exercise.
Analytical techniques
Calculation of carbohydrate and fat oxidation. Oxygen and carbon dioxide in the expired air was analyzed using Exerstress OX21 and CO21 electronic analyzers (Clinical Engineering Solutions, Sydney, Australia) calibrated with gases of known composition. Gas volume was measured using a dry gas meter (American Meter Company, Vacumed, Ventura, CA) calibrated against a Tissot spirometer. Expired air analysis was used to calculate oxygen consumption, carbon dioxide production, fat oxidation, and carbohydrate oxidation (34) . Blood analysis. Plasma glucose and lactate were determined using an automated glucose oxidase and L-lactate oxidase method, respectively (YSI 2300 Stat; Yellow Springs Instruments, Yellow Springs, OH), plasma nonesterified fatty acids (NEFAs) by an enzymatic colorimetric procedure (NEFA-C test; Wako, Osaka, Japan), and plasma insulin using a human insulin-specific radioimmunoassay kit (Linco Research, St. Charles, MO). Glucose kinetics at rest and during exercise were estimated using a modified one-pool nonsteady-state model, as proposed by Steele et al. (35) , which has been validated by Radziuk et al. (36) . We assumed 0.65 as the rapidly mixing portion of the glucose pool and estimated the apparent glucose space as 25% of body weight. Rates of plasma glucose appearance (R a ) and disappearance (R d ) were determined from the changes in percent enrichment of [6,6- 2 H]glucose and plasma glucose concentration. The muscles of the legs account for 80 -85% of tracer-determined whole-body glucose uptake during exercise at 55-60% VO 2max and probably a greater proportion during more intense exercise (37) . During exercise at 50% of VO 2max workload, Ͼ95% of tracer-determine glucose uptake is oxidized (37) . Muscle analysis. A portion (ϳ20 mg) of each muscle sample was freezedried and then crushed to a powder with any visible connective tissue removed. Muscle glycogen was extracted by incubating the sample in HCl then NaOH and then analyzed for glucose units using an enzymatic fluorometric method (38) . Muscle metabolites (ATP, creatine phosphate, creatine, and lactate) were extracted using the procedure of Harris et al. (39) and analyzed using enzymatic fluorometric techniques (40) . Free ADP and free AMP were calculated as outlined previously (17) .
Approximately 70 mg of each frozen muscle biopsy sample (non-freezedried) was homogenized in buffer A (50 mmol/l Tris-HCl, pH 7.5, 1 mmol/l EDTA, 1 mmol/l EGTA, 1 mmol/l dithiothreitol, 50 mmol/l NaF, 5 mmol/l Na pyrophosphate, 10% glycerol, 1% Triton X-100, 10 g/ml trypsin inhibitor, 2 g/ml aprotinin, 1 mmol/l benzamidine, and 1 mmol/l phenylmethylsulfonyl fluoride). The homogenates were incubated with the AMPK ␣1 or ␣2 antibody-bound protein A beads for 2 h at 4°C. Immunocomplexes were washed with PBS and suspended in 50 mmol/l Tris-HCl buffer (pH 7.5) for AMPK activity assay (41) . The AMPK activities in the immune complexes were measured in either the presence or absence of 200 mol/l AMP. Activities were calculated as picomoles of phosphate incorporated into the SAMS peptide [ACC␣ (73-87)A 77 ] per minute per milligram total protein subjected to immunoprecipitate.
AMPK kinase assays were performed using a two-step reaction with a maltose binding protein (MBP)-AMPK (1-312) fusion construct as substrate (42) . The construct consists of the AMPK catalytic core, which is activated after phosphorylation on the activation loop Thr-172. First, the AMPK kinase buffer contained 20 mmol/l Tris-HCl, pH 7.5, 0.1% Tween-20, 10 mmol/l dithiothreitol, 8 mmol/l MgCl 2 with 0.4 mmol/l ATP, and 0.12 mmol/l AMP, and MBP-AMPK (1-312) (5 mol/l) in 19 l was incubated with 11 l of the muscle homogenate at 30°C for 30 min. Second, the MBP-AMPK (1-312) activity was determined using the AMPK "SAMS" peptide assay, and a 10-l aliquot of the AMPK kinase reaction was added to the peptide phosphorylation reaction to give a final volume of 40 l comprising 50 mmol/l HEPES, pH 7.5, 12 mmol/l MgCl 2 , 5% glycerol, 0.05% Triton X-100 with 1 mmol/l dithiothreitol, 0.25 mmol/l [␥-32 P]ATP (500 cpm/pmol), 100 mol/l SAMS peptide, and 0.18 mmol/l AMP. After incubation for 10 min at 30°C, 30-l aliquots were applied to P81 papers as previously described (43) and activities (picomoles of phosphate transferred to the SAMS peptide per minute per milligram protein) were calculated. The AMPK kinase assay was characterized using crude extracts of rat muscle over the same activity range and was linear with time over 30 min. The background activity due to phosphorylation of the SAMS peptide in the absence of added MBP-AMPK (1-312) is subtracted from the activity because of the presence of the substrate (42) . Using recombinant CaM kinase I kinase as a surrogate AMPK kinase, we have shown that recombinant MBP-AMPK (1-312) requires phosphorylation on Thr-172 for activity. The activity of MBP-AMP (1-312) is independent of AMP, and its phosphorylation by AMPK is independent of AMP (S.M. and B.E.K., unpublished data).
ACC␤ and nNOS were affinity purified from muscle homogenates using monomeric Avidin agarose beads and 2Ј,5Ј-ADP Sepharose beads, respectively. The ACC␤ fraction was subjected to SDS-PAGE, and ACC␤ was detected by immunoblotting with anti-phospho-ACC␣-Ser-221 polyclonal antibody (17) and horseradish peroxidase-conjugated streptavidin (Amersham Biosciences U.K., Little Chalfont, U.K.). A monoclonal anti-phospho-ACC antibody (05-673) with the similar properties is now available from Upstate Biotechnology (Lake Placid, NY). The nNOS fraction was subjected to SDS-PAGE, and nNOS was detected by immunoblotting with anti-phosphonNOS-Ser-1451 polyclonal antibody (17) and human nNOS antibody (N31020; Transduction Laboratory, Lexington, KY). All data are expressed in quantitative densitometric arbitrary units. Statistical analysis. Results were analyzed using one-way repeated-measures ANOVA using the SPSS statistical package. Specific differences were located using the least significant difference test. A significance level of P Ͻ 0.05 was set.
RESULTS
Oxygen consumption progressively increased (P Ͻ 0.05) with each workload (Table 1) . Respiratory exchange ratio also increased (P Ͻ 0.05) progressively; however, respiratory exchange ratio was not significantly different between medium and high intensity. Carbohydrate oxidation progressively increased (P Ͻ 0.05) from resting through to high intensity. Fat oxidation increased (P Ͻ 0.05) from resting to low intensity, plateaued from low to medium intensity (P Ͼ 0.05), and decreased (P Ͻ 0.05) back to approximately resting levels during high intensity (Table  1) .
NEFA concentration remained essentially unchanged from resting to low intensity, then decreased (P Ͻ 0.05) from low to medium/high intensity ( Table 2) . Plasma insulin concentration decreased (P Ͻ 0.05) from resting to low intensity and remained relatively constant between low and medium intensity, before decreasing further during high intensity (Table 2) . Plasma lactate remained essentially unchanged from resting to low intensity but increased (P Ͻ 0.05) from low to medium to high intensity ( Table 2 ). Plasma glucose concentration remained essentially constant throughout the exercise trial ( Table 2) . Glucose R a was not significantly increased during low intensity, but then increased (P Ͻ 0.05) during medium intensity and increased further during high intensity (Table 2). Glucose R d followed the same general trend as glucose R a -not increasing significantly during low intensity, but then increasing during medium intensity (P Ͻ 0.05) and increasing further during high intensity (P Ͻ 0.05) ( Table 2) .
The muscle metabolite results, summarized in Table 3 , show no significant change (P Ͼ 0.05) in any measured muscle metabolite during exercise at low intensity compared with resting, but exercise resulted in a significant (P Ͻ 0.05) muscle energy imbalance at medium and high intensity. Exercise during medium intensity resulted in significant reductions (P Ͻ 0.05) in muscle glycogen and creatine phosphate and increases in muscle lactate, free AMP, free ADP, free AMP/ATP ratio, and creatine compared with both resting and low intensity. Exercise during high intensity resulted in further significant (P Ͻ 0.05) reductions in muscle glycogen and creatine phosphate and further increases (P Ͻ 0.05) in muscle free AMP, free ADP, free AMP/ATP ratio, and creatine compared with medium intensity. Muscle lactate tended to increase from medium to high intensity, but this was not significant. Muscle ATP content was not significantly affected by any of the exercise intensities (P Ͼ 0.05).
There was substantial constitutive AMPK kinase activity at rest (Fig. 1) . AMPK kinase activity did not increase significantly from resting to low intensity and increased (P Ͻ 0.05) modestly (ϳ1.5-fold) during medium intensity, plateauing during high intensity (Fig. 1) . There was no significant increase in AMPK ␣1 or ␣2 activities from resting to low intensity. AMPK ␣1 activity increased ϳ1.5-fold during exercise at medium intensity (P Ͻ 0.05) but remained relatively unchanged during high intensity ( Data are means Ϯ SE. *Different from resting (P Ͻ 0.05), †different from low intensity (P Ͻ 0.05), and ‡different from medium intensity (P Ͻ 0.05). n ϭ 8.
2A). AMPK ␣2 activity increased (P Ͻ 0.05) by approximately fivefold during medium intensity and by approximately eightfold during high intensity compared with resting (Fig. 2B) . A large progressive increase (P Ͻ 0.05) in phosphorylation of ACC␤ at Ser-221 occurred as exercise intensity increased (Fig. 3) . The fold increase (P Ͻ 0.05) in phosphorylation of ACC␤ was ϳ3-, ϳ8-, and ϳ10-fold during exercise at low, medium, and high intensity, respectively, compared with resting. nNOS phosphorylation tended to increase from resting to low intensity, then increased significantly during medium intensity, and then increased (P Ͻ 0.05) further during high intensity. The significant increase in ACC␤ phosphorylation from resting to low intensity accompanied the trend for an increase in calculated free AMP from 0.6 to 1.0 (mol/kg dry wt, Table  3 ), indicating that ACC␤ phosphorylation was particularly sensitive to the energy demands of exercise.
DISCUSSION
Activation of AMPK depends on phosphorylation at the activation loop Thr-172 by an upstream AMPK kinase(s), and AMPK activity can be further stimulated allosterically by AMP. AMPK kinase activity has not previously been investigated directly in skeletal muscle, although phosphorylation of AMPK Thr-172 by AMPK kinase has been demonstrated in skeletal muscle during exercise (4 -6).
The results obtained in the present study indicate that there is substantial AMPK kinase activity at rest, in marked contrast to the low resting levels of AMPK activity in skeletal muscle. There was only a modest but significant increase in skeletal muscle AMPK kinase activity during exercise. The high level of AMPK kinase activity indicates that other factors are likely to be important at rest to maintain the AMPK in the inactive dephosphorylated state.
Because AMPK kinase activity was measured in crude extracts, we cannot rule out the possibility that important allosteric regulators may have been diluted out. It has been reported that AMP binding to AMPK makes it a better substrate for AMPK kinase, and this may explain the low level of AMPK activity in resting muscle despite the presence of high AMPK kinase constitutive activity (44) . AMPK ␣1 activity mirrored the change in AMPK kinase activity at each workload, but, unlike AMPK kinase activity, AMPK ␣2 activity increased greatly during moderate exercise and then increased further during highintensity exercise. The apparent increase in AMPK ␣2 activity from 60 to 80% VO 2 peak may reflect the fivefold increase in free AMP/ATP ratio from 60 to 80% VO 2 peak. Further, because there was only a small increase in AMPK kinase activity during exercise compared with AMPK ␣2 activity, it appears that the major regulation of AMPK ␣2 activity during exercise is at the level of AMPK ␣2 rather than AMPK kinase. It is not known whether the apparent increase in AMPK kinase activity during exercise was due to posttranslational modification. Allosteric control of AMPK kinase due to accumulation of AMP in the biopsy extract was considered a possibility based on the report that AMP directly activated partially purified AMPK kinase (45) . However, we have tested AMP activation of partially purified AMPK kinase from skeletal muscle, heart muscle, kidney, and liver, and in no case was the AMPK kinase activity stimulated by AMP when MBP-AMP ␣ (1-312) was used as a substrate (S.M. and B.E.K., unpublished data). It has recently been shown that AMPK phosphorylation at Thr-172 increases during in situ stimulations in rat gastrocnemius muscle (5) . A correlation between AMPK activity and Thr-172 phosphorylation was also observed (5). Insufficient muscle biopsy material in the present study was available to correlate Thr-172 phosphorylation with AMPK activity; however, our results suggest that Thr-172 phosphorylation measurements are not a surrogate for direct AMPK kinase activity measurements. The responsiveness of AMPK activity correlates inversely with the concentration of muscle glycogen (46) . Contraction at a low or moderately reduced muscle glycogen content results in a greater level of activation of AMPK during contractions than when starting with a very high muscle glycogen in both rats (46) and humans (47) . The progressive decrease in muscle glycogen content during exercise in the present study paralleled the progressive increase in AMPK ␣2 activity with increasing workload. The mechanism underlying the inverse relationship between muscle glycogen content and AMPK activation is not known. Addition of glycogen to purified rat liver AMPK does not alter its activity (S.M. and B.E.K., unpublished data) so that suppression of AMPK activation in the presence of high muscle glycogen is not a direct effect of glycogen but rather a consequence of other factors.
Importantly, ACC␤ phosphorylation increased during exercise at 40% VO 2 peak (Fig. 3) , despite no detectable in vitro increase in AMPK activity at this low intensity of exercise (Fig. 2) . Previously we have shown that AMPK is associated with ACC␤ in skeletal muscle (16) . This suggests that ACC␤ phosphorylation is an especially sensitive measure of in vivo AMPK signaling. Although the trend increase in the free AMP level from rest to 40% VO 2 peak was not statistically significant, the downstream ACC␤ phosphorylation was. Similarly, low frequency stimulation in situ and low-intensity running in rats increases skeletal muscle ACC␤ phosphorylation and decreases ACC␤ activity without a detectable increase in stable AMPK activity (5) . We interpret this as indicating that AMPK is very tightly coupled to the metabolic needs of contracting skeletal muscle.
There is evidence that factors other than malonyl-CoA are important in regulating the transport of fatty acids into the mitochondria during exercise in humans (13, 22, 23, 48) . The decrease in malonyl-CoA observed by others during exercise at Ն85% VO 2 peak (22) would be expected to increase fat oxidation, but fat oxidation decreases during this intensity of exercise compared with lower intensities (12,13) ( Table 1 ). The reduction in calculated fat oxidation during high-intensity exercise in the present study involving relatively untrained individuals was more exaggerated than previous studies using endurance-trained subjects (12, 13) . Free carnitine decreases with increases in exercise intensity in human skeletal muscle, and it has been suggested that the reduced free carnitine would impair CPT1 activity (13) . In addition, there is evidence in humans that the reduction in muscle pH observed during intense exercise may inhibit CPT1 (49) . It is also possible that there is a reduction in oxygen in some fibers as the exercise intensity increases resulting in reduced reliance on fat oxidation (50) and that the increased reliance on fast-twitch muscle fibers at high intensities of exercise reduces fat oxidation. The pattern of response of skeletal muscle AMPK ␣2 activity and whole-body glucose uptake to increases in exercise intensity were more similar than that of AMPK ␣1 activity and glucose uptake, suggesting that AMPK ␣2 may be more directly coupled to glucose uptake than AMPK ␣1. It should be noted, however, that the data of two recent studies suggest that AMPK activity and glucose uptake during exercise/contraction do not correlate under conditions of high muscle glycogen levels (46, 47) . Indeed, although whole-body glucose disposal and AMPK ␣2 activity did not increase significantly during exercise at 40% VO 2 peak in the present study, it is known that contracting skeletal muscle glucose uptake increases at this intensity (51, 52) .
A small but significant increase in AMPK ␣1 activity during moderate-intensity exercise was observed in the present study. Previously, we found no significant increase in AMPK ␣1 activity during 30 min of exercise at 60% VO 2 peak (16), and others (14, 15) have found no increase in AMPK ␣1 activity at 50 and 70% VO 2 max. This variation may depend on the relative contribution of AMPK ␣1 activation due to allosteric versus Thr-172 phosphorylation control.
We have shown that nNOS is a target for phosphorylation by AMPK in human skeletal muscle (17) . We found a significant increase in phosphorylation of nNOS at Ser-1451 immediately after maximal sprint exercise (17) but only modest effects during lower-intensity exercise at ϳ60% VO 2 peak (16). In the current study, nNOS phosphorylation was also quite variable between subjects and only achieved statistically significant increases at the highest levels of exercise intensity (Fig. 4) . The pattern of response of nNOS phosphorylation and glucose uptake during exercise of increasing intensity was quite similar.
It is possible that some of the observed effects in the present study may have been due in part to the sequential nature of the protocol. However, the increases in glucose disposal (53) and AMPK ␣2 activity (54) during exercise were much greater than would be expected from the exercise duration alone, so they must have mainly been an effect of exercise intensity.
In summary, we have found that AMPK kinase is substantially active in resting human skeletal muscle and only modestly increased with exercise. Because AMPK ␣1 and ␣2 are essentially inactive at rest, these results are consistent with the idea that the increase in AMP during exercise acts allosterically on AMPK to make it more susceptible to phosphorylation at Thr-172 by AMPK kinase. The modest increase in AMPK kinase activity mirrored that of AMPK ␣1 activity in that they were both unchanged during exercise at 40% VO 2 peak and then increased to a similar extent during exercise at 60% VO 2 peak, with no further increase at 80% VO 2 peak. AMPK ␣2 activity exhibited a similar pattern to whole-body glucose use during exercise, with no changes during low-intensity exercise but progressive increases at the higher exercise intensities. Although not measured, it is likely that contracting skeletal muscle glucose uptake increased during low-intensity exercise. ACC␤ phosphorylation increased during low-intensity exercise without a measurable increase in AMPK activity and progressively increased with increases in exercise intensity. We interpret these results as indicating that the increase in ACC␤ phosphorylation during low-intensity exercise results from allosteric activation of AMPK by AMP.
